Support 110 years of independent journalism.

Good news on a Covid-19 vaccine and treatments leaves Rishi Sunak with a new challenge

Positive news on the health front may mean the Chancellor opts to revisit his planned withdrawal of economic support. 

By Stephen Bush

Two major breakthroughs, both made in British universities, have put the world a major step closer to beating coronavirus. Preliminary trials for the University of Oxford’s vaccine project show that it produces a strong immune response and is “well-tolerated”: meaning it produces few notable side effects. Equally importantly, an early trial by a team at the University of Southampton has found that beta-interferon can reduce the severity of Covid-19 in the vast majority of cases.

Taken together, they are hugely hopeful advances that may mean that the novel coronavirus is rendered non-lethal for all but a tiny minority. Palliative treatments are as important as the development of a vaccine, since while some vaccines work in close to 100 per cent of cases, others work less well – and it’s important to be able to prevent the disease as well as treat its symptoms.

Both positive stories raise questions for the UK’s economic response to the coronavirus recession over the coming months. At present, the government plans to withdraw much of its support for businesses and households by the end of October – a sensible timetable if we have to live with the virus for a long time, and if society will have to adjust to a significantly curtailed level of social contact, in which many current businesses will become unviable and new ones will gradually emerge.

But if physical distancing is to be a happily brief phenomenon, either because of the development of a vaccine or palliative treatments, both of which look closer now than they did even a week ago, then the economic case for continuing measures to preserve as much pre-crisis activity in aspic has become considerably stronger. There will be some permanent economic changes, of course, as a result of the trend towards more distanced working among other behavioural changes, but the case for ending the protections extended to businesses and institutions that cannot operate in the era of social distancing, when the prospects for either palliative treatment or a vaccine both look good, is considerably weaker than it appeared on Friday.

The positive news on the health front ought to trigger a revisiting of some of the assumptions underpinning the Chancellor Rishi Sunak’s spending decisions only a few weeks ago. 

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
  • Administration / Office
  • Arts and Culture
  • Board Member
  • Business / Corporate Services
  • Client / Customer Services
  • Communications
  • Construction, Works, Engineering
  • Education, Curriculum and Teaching
  • Environment, Conservation and NRM
  • Facility / Grounds Management and Maintenance
  • Finance Management
  • Health - Medical and Nursing Management
  • HR, Training and Organisational Development
  • Information and Communications Technology
  • Information Services, Statistics, Records, Archives
  • Infrastructure Management - Transport, Utilities
  • Legal Officers and Practitioners
  • Librarians and Library Management
  • Management
  • Marketing
  • OH&S, Risk Management
  • Operations Management
  • Planning, Policy, Strategy
  • Printing, Design, Publishing, Web
  • Projects, Programs and Advisors
  • Property, Assets and Fleet Management
  • Public Relations and Media
  • Purchasing and Procurement
  • Quality Management
  • Science and Technical Research and Development
  • Security and Law Enforcement
  • Service Delivery
  • Sport and Recreation
  • Travel, Accommodation, Tourism
  • Wellbeing, Community / Social Services
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
<strong>What you need to know about private markets </strong>
Work isn't working: how to boost the nation's health and happiness
The dementia crisis: a call for action